Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrence

International Journal of Cancer

Volumn 119, Issue 6, 2006, Pages 1440-1446

  Martínez, María Elena ^a,b   Giovannucci, Edward ^c,d   Jiang, Ruiyun ^a   Henning, Susanne M ^e   Jacobs, Elizabeth T ^a,b   Thompson, Patricia ^a,f   Smith Warner, Stephanie A ^c   Alberts, David S ^a,b,f  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Colorectal adenoma; Folate; Homocysteine

Indexed keywords

FOLIC ACID ANTAGONIST; HOMOCYSTEINE; MULTIVITAMIN; URSODEOXYCHOLIC ACID;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CANCER RECURRENCE; COLONOSCOPY; COLORECTAL ADENOMA; CONFIDENCE INTERVAL; DIET SUPPLEMENTATION; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UNITED STATES; VITAMIN SUPPLEMENTATION; WHEAT BRAN;

ADENOMA; AGED; COLORECTAL NEOPLASMS; DIET; DIETARY FIBER; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FOLIC ACID; FOOD, FORTIFIED; HOMOCYSTEINE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; URSODEOXYCHOLIC ACID; VITAMIN B COMPLEX;

EID: 33747515941     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21978     Document Type: Article

References (34)

1. Sanjoaquin MA, Allen N, Couto E, Roddam AW, Key TJ. Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer 2005;113:825-8.
2. Glynn SA, Albanes D, Pietinen P, Brown CC, Rautalahti M, Tangrea JA, Gunter EW. Barrett MJ, Virtamo J, Taylor PR. Colorectal cancer and folate status: a nested case-control study among male smokers. Cancer Epidemiol Biomarkers Prev 1996;5:487-94.
3. Kato I, Dnistrian AM, Schwartz M, Toniolo P, Koenig K, Shore RE, Akhmedkhanov A, Zeleniuch-Jacquotte A, Riboli E. Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study. Br J Cancer 1999;79:1917-21.
4. Martinez ME, Henning SM, Alberts DS. Folate and colorectal neoplasia: relationship between plasma and dietary markers of folate and ad-enoma recurrence. Am J Clin Nutr 2004;79:691-7.
5. Choi SW, Mason JB. Folate status: effects on pathways of colorectal carcinogenesis. J Nutr 2002;132:24135-24185.
6. Kim YI. Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem 1999;10:66-88.
7. Duthie SJ. Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull 1999;55:578-92.
8. Choi SW, Mason JB. Folate and carcinogenesis: an integrated scheme. J Nutr 2000;130:129-32.
9. Strain JJ, Dowey L, Ward M, Pentieva K, McNulty H. B-vitamins, homocysteine metabolism and CVD. Proc Nutr Soc 2004;63:597-603.
10. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989;114:473-501.
11. Foulke J. Folic acid to fortify US food products to prevent birth defects [press release]. US Food and Drug Administration, 1996.
12. Health Canada. Regulations amending the food and drug regulations (Schedule No. 1066). Canada Gazette (Part 1) 1997;131:3702-37.
13. Alberts DS, Martinez ME, Roe DJ, Guillen-Rodriguez JM, Marshall JR, van Leeuwen JB, Reid ME, Ritenbaugh C, Vargas PA, Bhattacharyya AB, Earnest DL, Sampliner RE. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N Engl J Med 2000;342:1156-62.
14. Alberts DS, Martínez ME, Hess LS, Einspahr JG, Green SB, Bhattacharyya AK, Guillen J, Krutzsch M, Batta AK, Salen G, Fales L, Koonce K, et al. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J Natl Cancer Inst 2005;97:846-53.
15. Jacques PF, Selhub J, Bostom AG, Wilson P, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340:1449-545.
16. Kuo K, Still R, Cale S, McDowell I. Standardization (external and internal) of HPLC assay for plasma homocysteine. Clin Chem 1997;43:1653-5.
17. Martinez ME, Sampliner R, Marshall JR, Bhattacharyya AB, Reid ME, Alberts DS. Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology 2001;120:1077-83.
18. Ervin RB, Wright JD, Reed-Gillette D. Prevalence of leading types of dietary supplements used in the third national health and nutrition ex-amination survey, 1988-94. National Center for Health Statistics, MD, 2004. Adv Data No. 349, pp. 1-7.
19. Hosmer DW, Lemeshow S. Applied logistic regression, 2nd edn. New York: Wiley, 2000.
20. Lewis CA, Pancharuniti N, Sauberlich HE. Plasma folate adequacy as determined by homocysteine level. Ann NY Acad Sci 1992;669:360-2.
21. Liu S, West R, Randell E, Longerich L, O'Connor KS, Scott H, Crowley M, Lam A, Prabhakaran V, McCourt C. A comprehensive evaluation of food fortification with folic acid for the primary prevention of neural tube defects. BMC Pregancy Childbirth 2004;4:1-10.
22. 6 and the risk of colorectal cancer and adenoma in women. J Natl Cancer Inst 2005;97:684-92.
23. Martinez ME. Hormone replacement therapy and adenoma recurrence: implications for its role in colorectal cancer risk. J Natl Cancer Inst 2001;93:1764,1765.
24. Kim YI. Role of folate in colon cancer development and progression. J Nutr 2003;133:3731S-3739S.
25. Cravo ML, Mason JB, Dayal Y, Hutchinson M, Smith D, Selhub J, Rosenberg IH. Folate deficiency enhances the development of colonic neoplasia in dimethylhydrazine-treated rats. Cancer Res 1992;52: 5002-6.
26. Kim Y-I, Salomon RN, Graeme-Cook F, Choi SW, Smith DE, Dallai GE, Mason JB. Dietary folate protects against the development of macroscopic colonic neoplasia in a dose responsive manner in rats. Gut 1996;39:732-40.
27. Le Leu RK, Young GP, McIntosh GH. Folate deficiency reduces the development of colorectal cancer in rats. Carcinogenesis 2000;21:2261-5.
28. Min mouse. Cancer Res 2000;60:5434-40.
29. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong L-Y. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001;285:2981-6.
30. Lawrence JM, Petitti DB, Watkins M, Umekubo MA. Trends in serum folate after food fortification. Lancet 1999;354:915-16.
31. Ganji V, Kafai MR. Trends in serum folate, RBC folate, and circulating total homocysteine concentrations in the United States: analysis of data from national health and nutrition examination surveys, 1988-1994, 1999-2000, and 2001-2002. J Nutr 2006;136:153-8.
32. Cravo M, Fidalgo P, Pereira A, Gouveia-Oliveira A, Chavas P, Selhub J, Mason J, Mira F, Leitao C. DNA methylation as an intermediate biomarker in colorectal cancer: modulation by folic acid supplementation. Eur J Cancer Prev 1994;3:473-9.
33. Paspatis GA, Kalafatis E, Oros L, Xourgias V, Koutsioumpa P, Kamanolis D. Folate status and adenomatous colonic polyps. A colonoscopically controlled study. Dis Colon Rectum 1995;38:64-7.
34. Kim Y-I, Baik HW, Fawaz K, Knox T, Lee YM, Norton R, Libby E, Mason JB. Effects of folate supplementation on two provisional molecular markers of colon cancer: a prospective, randomized trial. Am J Gastroenterol 2001;96:184-95.